Pseudocannabinoid H4CBD improves glucose response during advanced metabolic syndrome in OLETF rats independent of increase in insulin signaling proteins.

Saved in:
Bibliographic Details
Title: Pseudocannabinoid H4CBD improves glucose response during advanced metabolic syndrome in OLETF rats independent of increase in insulin signaling proteins.
Authors: Wilson JN; Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, California, United States., Mendez DA; Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, California, United States., Dhoro F; Department of Chemistry, University of California, Davis, California, United States., Shevchenko N; Department of Chemistry, University of California, Davis, California, United States., Mascal M; Department of Chemistry, University of California, Davis, California, United States., Lund K; Department of Pathology, University of California, San Diego, California, United States., Fitzgerald R; Department of Pathology, University of California, San Diego, California, United States., DiPatrizio NV; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, California, United States., Ortiz RM; Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, California, United States.
Source: American journal of physiology. Regulatory, integrative and comparative physiology [Am J Physiol Regul Integr Comp Physiol] 2024 Feb 01; Vol. 326 (2), pp. R100-R109. Date of Electronic Publication: 2023 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1490 (Electronic) Linking ISSN: 03636119 NLM ISO Abbreviation: Am J Physiol Regul Integr Comp Physiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1522-1490
DOI:10.1152/ajpregu.00125.2022